Madras Fertilizers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 27, 2025, 12:47 pm

Quick Insight

Madras Fertilizers Ltd, with a current share price of 89.2 and a market capitalization of 1,436 Cr., exhibits a P/E ratio of 21.2, indicating a solid earnings performance. However, the company's ROE stands at an unspecified figure, suggesting room for improvement in shareholder returns. With a ROCE of 10.5%, Madras Fertilizers is utilizing its capital efficiently. The negative reserves of -194 Cr. and high borrowings of ₹1,594 Cr. raise concerns about its financial health and leverage. Furthermore, the low OPM of 10% reflects potential inefficiencies in operations. In conclusion, while the company shows promise in earnings and capital utilization, addressing its financial structure and operational efficiency could enhance its overall performance and investor confidence.

Competitors of Madras Fertilizers Ltd

All Competitor Stocks of Madras Fertilizers Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:30 am

Below is a detailed analysis of the quarterly data for Madras Fertilizers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 672.00 Cr.. The value appears strong and on an upward trend. It has increased from 555.00 Cr. (Mar 2025) to 672.00 Cr., marking an increase of 117.00 Cr..
• For Expenses, as of Jun 2025, the value is 607.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 616.00 Cr. (Mar 2025) to 607.00 Cr., marking a decrease of 9.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 65.00 Cr.. The value appears strong and on an upward trend. It has increased from -61.00 Cr. (Mar 2025) to 65.00 Cr., marking an increase of 126.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from -11.00% (Mar 2025) to 10.00%, marking an increase of 21.00%.
• For Other Income, as of Jun 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Mar 2025) to 13.00 Cr., marking a decrease of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
• For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from -64.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 123.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from -19.00% (Mar 2025) to 25.00%, marking an increase of 44.00%.
• For Net Profit, as of Jun 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from -52.00 Cr. (Mar 2025) to 44.00 Cr., marking an increase of 96.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.73. The value appears strong and on an upward trend. It has increased from -3.26 (Mar 2025) to 2.73, marking an increase of 5.99.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:53 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:46 am

Below is a detailed analysis of the balance sheet data for Madras Fertilizers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 162.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 162.00 Cr..
• For Reserves, as of Mar 2025, the value is -194.00 Cr.. The value appears to be improving (becoming less negative). It has improved from -352.00 Cr. (Mar 2024) to -194.00 Cr., marking an improvement of 158.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,594.00 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 1,583.00 Cr. (Mar 2024) to 1,594.00 Cr., marking an increase of 11.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 671.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 614.00 Cr. (Mar 2024) to 671.00 Cr., marking an increase of 57.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,233.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,007.00 Cr. (Mar 2024) to 2,233.00 Cr., marking an increase of 226.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 207.00 Cr.. The value appears strong and on an upward trend. It has increased from 200.00 Cr. (Mar 2024) to 207.00 Cr., marking an increase of 7.00 Cr..
• For CWIP, as of Mar 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 25.00 Cr. (Mar 2024) to 20.00 Cr., marking a decrease of 5.00 Cr..
• For Investments, as of Mar 2025, the value is 525.00 Cr.. The value appears strong and on an upward trend. It has increased from 455.00 Cr. (Mar 2024) to 525.00 Cr., marking an increase of 70.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,482.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,328.00 Cr. (Mar 2024) to 1,482.00 Cr., marking an increase of 154.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,233.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,007.00 Cr. (Mar 2024) to 2,233.00 Cr., marking an increase of 226.00 Cr..

However, the Borrowings (1,594.00 Cr.) are higher than the Reserves (-194.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Madras Fertilizers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 0.35. This value is below the healthy minimum of 5. It has decreased from 11.50 (Mar 23) to 0.35, marking a decrease of 11.15.
• For Diluted EPS (Rs.), as of Mar 24, the value is 0.35. This value is below the healthy minimum of 5. It has decreased from 11.50 (Mar 23) to 0.35, marking a decrease of 11.15.
• For Cash EPS (Rs.), as of Mar 24, the value is 0.97. This value is below the healthy minimum of 3. It has decreased from 12.02 (Mar 23) to 0.97, marking a decrease of 11.05.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -11.70. It has increased from -17.70 (Mar 23) to -11.70, marking an increase of 6.00.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -11.70. It has increased from -17.70 (Mar 23) to -11.70, marking an increase of 6.00.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 137.44. It has decreased from 212.60 (Mar 23) to 137.44, marking a decrease of 75.16.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 8.90. This value is within the healthy range. It has decreased from 20.75 (Mar 23) to 8.90, marking a decrease of 11.85.
• For PBIT / Share (Rs.), as of Mar 24, the value is 8.27. This value is within the healthy range. It has decreased from 20.16 (Mar 23) to 8.27, marking a decrease of 11.89.
• For PBT / Share (Rs.), as of Mar 24, the value is 0.73. This value is within the healthy range. It has decreased from 15.34 (Mar 23) to 0.73, marking a decrease of 14.61.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 0.34. This value is below the healthy minimum of 2. It has decreased from 11.43 (Mar 23) to 0.34, marking a decrease of 11.09.
• For PBDIT Margin (%), as of Mar 24, the value is 6.47. This value is below the healthy minimum of 10. It has decreased from 9.76 (Mar 23) to 6.47, marking a decrease of 3.29.
• For PBIT Margin (%), as of Mar 24, the value is 6.01. This value is below the healthy minimum of 10. It has decreased from 9.48 (Mar 23) to 6.01, marking a decrease of 3.47.
• For PBT Margin (%), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 10. It has decreased from 7.21 (Mar 23) to 0.53, marking a decrease of 6.68.
• For Net Profit Margin (%), as of Mar 24, the value is 0.24. This value is below the healthy minimum of 5. It has decreased from 5.37 (Mar 23) to 0.24, marking a decrease of 5.13.
• For Return on Networth / Equity (%), as of Mar 24, the value is -2.93. This value is below the healthy minimum of 15. It has increased from -64.55 (Mar 23) to -2.93, marking an increase of 61.62.
• For Return on Capital Employeed (%), as of Mar 24, the value is -397.12. This value is below the healthy minimum of 10. It has decreased from -201.93 (Mar 23) to -397.12, marking a decrease of 195.19.
• For Return On Assets (%), as of Mar 24, the value is 0.27. This value is below the healthy minimum of 5. It has decreased from 9.98 (Mar 23) to 0.27, marking a decrease of 9.71.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 24, the value is -8.35. This value is within the healthy range. It has decreased from -5.20 (Mar 23) to -8.35, marking a decrease of 3.15.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.15. It has decreased from 1.83 (Mar 23) to 1.15, marking a decrease of 0.68.
• For Current Ratio (X), as of Mar 24, the value is 0.63. This value is below the healthy minimum of 1.5. There is no change compared to the previous period (Mar 23) which recorded 0.63.
• For Quick Ratio (X), as of Mar 24, the value is 0.52. This value is below the healthy minimum of 1. It has increased from 0.51 (Mar 23) to 0.52, marking an increase of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 7.53. This value is within the healthy range. It has decreased from 9.64 (Mar 23) to 7.53, marking a decrease of 2.11.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 2.00. This value is below the healthy minimum of 3. It has decreased from 4.30 (Mar 23) to 2.00, marking a decrease of 2.30.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.77. This value is below the healthy minimum of 3. It has decreased from 3.37 (Mar 23) to 1.77, marking a decrease of 1.60.
• For Enterprise Value (Cr.), as of Mar 24, the value is 2,323.97. It has increased from 2,029.98 (Mar 23) to 2,323.97, marking an increase of 293.99.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.05. This value is within the healthy range. It has increased from 0.58 (Mar 23) to 1.05, marking an increase of 0.47.
• For EV / EBITDA (X), as of Mar 24, the value is 16.16. This value exceeds the healthy maximum of 15. It has increased from 6.03 (Mar 23) to 16.16, marking an increase of 10.13.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.58. This value is below the healthy minimum of 1. It has increased from 0.27 (Mar 23) to 0.58, marking an increase of 0.31.
• For Price / BV (X), as of Mar 24, the value is -6.92. This value is below the healthy minimum of 1. It has decreased from -3.26 (Mar 23) to -6.92, marking a decrease of 3.66.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.58. This value is below the healthy minimum of 1. It has increased from 0.27 (Mar 23) to 0.58, marking an increase of 0.31.
• For EarningsYield, as of Mar 24, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.19 (Mar 23) to 0.00, marking a decrease of 0.19.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness